What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Disease
Alzheimer's disease, Dementia, Pathology, Pittsburgh compound B and Internal medicine are his primary areas of study.
Alzheimer's disease is a subfield of Disease that Christopher C. Rowe studies.
His Disease study incorporates themes from Biomarker, Cognition, Neuroimaging and Case-control study.
His research in Dementia intersects with topics in Cerebellar cortex, Episodic memory, Gerontology and Clinical psychology.
In his research, Neocortex and Precuneus is intimately related to Posterior cingulate, which falls under the overarching field of Pathology.
He has included themes like Diabetes mellitus and Oncology in his Internal medicine study.
His most cited work include:
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (4114 citations)
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease (2145 citations)
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1750 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Disease, Internal medicine, Alzheimer's disease, Pathology and Dementia.
Christopher C. Rowe is interested in Cognitive impairment, which is a field of Disease.
His Internal medicine research incorporates themes from Endocrinology, Oncology and Cardiology.
In Alzheimer's disease, Christopher C. Rowe works on issues like Neuroscience, which are connected to Neurodegeneration.
Christopher C. Rowe combines subjects such as Psychiatry, Neuroimaging, Prospective cohort study and Neuropsychology with his study of Dementia.
Christopher C. Rowe has researched Cognitive decline in several fields, including Cognition and Gerontology.
He most often published in these fields:
- Disease (30.11%)
- Internal medicine (28.66%)
- Alzheimer's disease (23.34%)
What were the highlights of his more recent work (between 2017-2021)?
- Disease (30.11%)
- Internal medicine (28.66%)
- Dementia (22.61%)
In recent papers he was focusing on the following fields of study:
Christopher C. Rowe spends much of his time researching Disease, Internal medicine, Dementia, Alzheimer's disease and Cognitive decline.
His Disease research is classified as research in Pathology.
He focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Cardiology and, in certain cases, Magnetic resonance imaging.
His research combines Atrophy and Dementia.
His work blends Alzheimer's disease and Clinical neurology studies together.
His Cognitive decline research incorporates elements of Apolipoprotein E, Cognition, Neuropsychology and Cohort.
Between 2017 and 2021, his most popular works were:
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease (2145 citations)
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease (497 citations)
- Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. (153 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
Christopher C. Rowe mostly deals with Alzheimer's disease, Internal medicine, Disease, Dementia and Cognitive decline.
His Alzheimer's disease research is multidisciplinary, relying on both Biomarker, Frontotemporal lobar degeneration, Amyloid beta and Neuroscience.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Temporal lobe, Oncology and Cardiology.
His Disease research integrates issues from Positron emission tomography, Prospective cohort study and Neuroimaging.
The Dementia study combines topics in areas such as Clinical syndrome, Cohort, Atrophy and Amyloid.
His Cognitive decline research includes themes of Audiology, Cognition, Ageing, Apolipoprotein E and Physiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
